An evidence-based review of poorly differentiated thyroid cancer

EMS Jr, VA LiVolsi, J Brierley, J Shin… - World journal of …, 2007 - Springer
Background Poorly differentiated thyroid cancer (PDTC) presents the endocrinologist and
surgeon with challenges of recognition and treatment given the lack of consensus on …

Comprehensive literature review: recent advances in diagnosing and managing patients with poorly differentiated thyroid carcinoma

J Hannallah, J Rose… - International Journal of …, 2013 - Wiley Online Library
Poorly differentiated thyroid carcinomas are a rare form of thyroid carcinomas; they display
an intermediate behavior between well‐differentiated and anaplastic thyroid carcinomas …

Poorly differentiated and anaplastic thyroid cancer

KN Patel, AR Shaha - Cancer control, 2006 - journals.sagepub.com
Background Poorly differentiated thyroid carcinoma (PDTC) and anaplastic
(undifferentiated) thyroid carcinoma (ATC) comprise a small subset of thyroid tumors that are …

Outcomes in patients with poorly differentiated thyroid carcinoma

T Ibrahimpasic, R Ghossein, DL Carlson… - The Journal of …, 2014 - academic.oup.com
Background: Poorly differentiated thyroid cancer (PDTC) accounts for only 1–15% of all
thyroid cancers. Our objective is to report outcomes in a large series of patients with PDTC …

Management of low-risk differentiated thyroid cancer

EL Mazzaferri - Endocrine Practice, 2007 - Elsevier
Objective To summarize the definitions of and management recommendations for low-risk
thyroid cancer made by the American and European Thyroid Associations and synthesize …

[PDF][PDF] Differentiated thyroid carcinoma: defining new paradigms for the post-operative management

C Durante, G Costante, S Filetti - Endocrine-related cancer, 2013 - academia.edu
The demography of differentiated thyroid cancers (DTCs) has changed considerably since
the 1990s, when the vast majority of these tumors were clinically evident at the time of …

Poorly differentiated carcinoma of the thyroid gland: current status and future prospects

T Ibrahimpasic, R Ghossein, JP Shah, I Ganly - Thyroid, 2019 - liebertpub.com
Background: Poorly differentiated thyroid cancer (PDTC) is a rare but clinically highly
significant entity because it accounts for most fatalities from non-anaplastic follicular cell …

The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008

W Sacks, CH Fung, JT Chang, A Waxman… - Thyroid, 2010 - liebertpub.com
Background: Radioactive iodine (RAI) remnant ablation has been used to eliminate normal
thyroid tissue and may also facilitate monitoring for persistent or recurrent thyroid carcinoma …

External‐beam radiotherapy for differentiated thyroid cancer locoregional control: a statement of the American Head and Neck Society

AP Kiess, N Agrawal, JD Brierley, U Duvvuri… - Head & …, 2016 - Wiley Online Library
The use of external‐beam radiotherapy (EBRT) in differentiated thyroid cancer (DTC) is
debated because of a lack of prospective clinical data, but recent retrospective studies have …

Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4

M Dietlein, W Eschner, F Gruenwald… - Nuklearmedizin …, 2016 - europepmc.org
The procedure guideline for radioiodine therapy of differentiated thyroid cancer (version 4)
was developed in the consensus of a representative expert group. This fulfils the level S1 …